Prospective observational multicenter study to evaluate the stability and quality of the visual function after the implantation of OptiBlue (ZCB00V) - Multicenter observational study of OptiBlue

Abbott Medical Optics Japan K.K.0 个研究点目标入组 800 人开始时间: 2013年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients who have known systemic pathology, ophthalmologic disease or the history of previous surgery that may potentially affect visual functions 2) Patients who have the history of previous corneal refractive surgery 3) Patients who have been implanted with a multifocal intraocular lens or toric lens 4) Patients who are taking or may take the medications that could potentially affect visual functions 5) Patients with severe lens opacity 6) Patients who have the abnormalities of lens capsule or zonule of Zinn due to the preoperative or intraoperative complications, and the abnormalities may potentially cause the incorrect positioning of the intraocular lens, which potentially affect visual functions 7) Patients who have the pupillary abnormalities including no response, pupillotonia, shape anomaly or the condition mydriatic action (pupil diameter of 4 mm or longer) is not observed in the crepuscule or dark situation 8) Patients who have an allergy to mydriatic agent 9) Other patients considered unsuited for the study by the investigators

发起方

Abbott Medical Optics Japan K.K.